A versatile toolkit for drug metabolism studies with GNPS2: from drug development to clinical monitoring
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yu, Jun Sang | - |
dc.contributor.author | Kwak, Young Beom | - |
dc.contributor.author | Kee, Kyung Hwa | - |
dc.contributor.author | Wang, Mingxun | - |
dc.contributor.author | Kim, Dong Hyun | - |
dc.contributor.author | Dorrestein, Pieter C. | - |
dc.contributor.author | Kang, Kyo Bin | - |
dc.contributor.author | Yoo, Hye Hyun | - |
dc.date.accessioned | 2025-09-22T05:30:22Z | - |
dc.date.available | 2025-09-22T05:30:22Z | - |
dc.date.issued | 2025-09 | - |
dc.identifier.issn | 1754-2189 | - |
dc.identifier.issn | 1750-2799 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/126525 | - |
dc.description.abstract | Metabolism is a fundamental process that shapes the pharmacological and toxicological profiles of drugs, making metabolite identification and analysis critical in drug development and biological research. Global Natural Products Social Networking (GNPS) is a community-driven infrastructure for mass spectrometry data analysis, storage and knowledge dissemination. GNPS2 is an improved version of the platform offering higher processing speeds, improved data analysis tools and a more intuitive user interface. Molecular networking based on tandem mass spectrometry spectral alignments, combined with other tools in the GNPS2 analysis environment, enables the discovery of candidate drug metabolites without prior knowledge, even from complex biological matrices. This protocol represents an extension of a previously established protocol for fundamental molecular networking in GNPS, with a specific focus on metabolism studies. This article uses the example of the drug sildenafil to identify candidate metabolites obtained from liquid chromatography-quadrupole time-of-flight mass spectrometry analysis of liver microsomal fractions and mice plasma to guide the reader through a step-by-step process consisting of five GNPS2-based analytical workflows. It demonstrates how the tools in GNPS2 can be used not only to identify candidate drug metabolites from in vitro studies but also to evaluate the translational relevance of these in vitro findings to humans by using reverse metabolomics. We provide a step-by-step analytical approach based on published studies to showcase how GNPS2 can be effectively applied in drug metabolism studies. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | NATURE PORTFOLIO | - |
dc.title | A versatile toolkit for drug metabolism studies with GNPS2: from drug development to clinical monitoring | - |
dc.type | Article | - |
dc.publisher.location | 독일 | - |
dc.identifier.doi | 10.1038/s41596-025-01237-6 | - |
dc.identifier.scopusid | 2-s2.0-105015476508 | - |
dc.identifier.wosid | 001566170800001 | - |
dc.identifier.bibliographicCitation | NATURE PROTOCOLS | - |
dc.citation.title | NATURE PROTOCOLS | - |
dc.type.docType | Review; Early Access | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.subject.keywordPlus | MASS-SPECTROMETRY DATA | - |
dc.subject.keywordPlus | MOLECULAR NETWORKING | - |
dc.subject.keywordPlus | METABOLOMICS | - |
dc.subject.keywordPlus | ANNOTATION | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | PLATFORM | - |
dc.subject.keywordPlus | SMILIB | - |
dc.subject.keywordPlus | MS/MS | - |
dc.subject.keywordPlus | XCMS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.